Interventional Latest News Archive

FDA Approves Eluvia Drug-Eluting Stent for Peripheral Artery Disease

FDA Approves Eluvia Drug-Eluting Stent for Peripheral Artery Disease

The Eluvia stent is designed to release paclitaxel for a 1-year time frame to prevent tissue regrowth that might otherwise block the stented artery.

LVAD in Heart Failure Linked to Improved Glycemic Control

LVAD in Heart Failure Linked to Improved Glycemic Control

HbA1c levels following left ventricular assist device implantation were statistically significantly lower than before surgery.

FDA Approves Device to Treat Acute Coronary Artery Perforations

FDA Approves Device to Treat Acute Coronary Artery Perforations

The Agency reviewed real-world data from 80 patients who received the PK Papyrus Stents, finding that the stents were delivered successfully to the perforation site in 95% of patients with successful seals seen in 73 patients 91.3% of patients.

SAVR vs TAVR: Adverse Outcomes Risk in Aortic Stenosis

SAVR vs TAVR: Adverse Outcomes Risk in Aortic Stenosis

Surgical and transcatheter aortic valve replacement had a similar risk for adverse outcomes in patients with severe aortic stenosis, regardless of whether or not the patients had prior cardiac surgery.

Ticagrelor Without Concomitant Aspirin No Better Than Standard DAPT in PCI

Ticagrelor Without Concomitant Aspirin No Better Than Standard DAPT in PCI

Ticagrelor without aspirin offered no additional benefits compared with conventional dual antiplatelet therapy in patients undergoing PCI for either CAD or ACS.

Radial Access Reduced Adverse Events in Intervention for Acute Coronary Syndrome

Radial Access Reduced Adverse Events in Intervention for Acute Coronary Syndrome

Net adverse cardiac events occurred in 15.2% of patients with radial access and 17.2% with femoral access while undergoing invasive therapies for acute coronary syndrome.

Optimal Dressing, Securement of Peripheral IV Catheters Not Yet Found

Optimal Dressing, Securement of Peripheral IV Catheters Not Yet Found

Tissue adhesive with polyurethane dressing, bordered polyurethane dressing, or using a securement device with polyurethane dressing were not superior to standard low-cost polyurethane dressing for peripheral intravenous catheters.

Hypothyroidism Predicts Atrial Tachyarrhythmia After AF Catheter Ablation

Hypothyroidism Predicts Atrial Tachyarrhythmia After AF Catheter Ablation

Patients with higher levels of thyroid-stimulating hormone were more likely to experience atrial tachyarrhythmia after catheter ablation for atrial fibrillation.

SYNTAX Score II Predicts Mortality in 1- and 2-Vessel Disease

SYNTAX Score II Predicts Mortality in 1- and 2-Vessel Disease

The SYNTAX score II was an independent predictor of mortality in patients with 1- and 2-vessel disease undergoing percutaneous coronary intervention.

Leadless Pacemakers Associated With Fewer Complications

Leadless Pacemakers Associated With Fewer Complications

Patients with leadless cardiac pacemakers experienced fewer short-term and midterm complications, but more pericardial effusions than patients with standard transvenous pacemakers.

Ischemic Stroke Risk Increased With Higher Platelet Reactivity Post-DES Implantation

Ischemic Stroke Risk Increased With Higher Platelet Reactivity Post-DES Implantation

High platelet reactivity was associated with an increased risk for ischemic stroke in patients who had undergone drug-eluting stent implantation.

Permanent Pacemaker After TAVR Increases Mortality, Readmission Risks

Permanent Pacemaker After TAVR Increases Mortality, Readmission Risks

Individuals who required a permanent pacemaker after transcatheter aortic valve replacement had an increased risk for mortality and hospital readmissions.

CTEPH Increases Risk for Sleep Disordered Breathing

CTEPH Increases Risk for Sleep Disordered Breathing

Precapillary pulmonary hypertension and obstructive sleep apnea may be causative factors for central sleep apnea and pulmonary hypertension, respectively.

FDA Recall: HeartMate 3™ Outflow Graft Assembly Malfunction

FDA Recall: HeartMate 3 Outflow Graft Assembly Malfunction

The HeartMate 3™ Left Ventricular Assist System has been recalled because of a potential malfunction in the outflow graft assembly that may cause it to twist and close up over time.

Transforming Congenital Heart Disease Outcomes With 3D Printing

Transforming Congenital Heart Disease Outcomes With 3D Printing

The use of 3D-printed models is transforming congenital heart disease care by improving clinical outcomes and medical training.

Ticagrelor Plus Aspirin Superior to Aspirin Alone for Post-CABG Graft Patency

Ticagrelor Plus Aspirin Superior to Aspirin Alone for Post-CABG Graft Patency

Ticagrelor plus aspirin was superior in increasing post-coronary artery bypass grafting patency compared with aspirin alone.

Transcatheter vs Surgical Aortic Valve Replacement in COPD

Transcatheter vs Surgical Aortic Valve Replacement in COPD

In patients with COPD, transcatheter aortic valve replacement was associated with fewer respiratory-related complications than surgical aortic valve replacement.

Loading Atorvastatin Doses Before and After PCI in ACS for MACE Prevention

Loading Atorvastatin Doses Before and After PCI in ACS for MACE Prevention

Major adverse cardiovascular events were not reduced in patients with acute coronary syndrome undergoing planned percutaneous coronary intervention when given 2 loading doses of atorvastatin.

Improved Outcomes With CABG vs PCI for Diabetes With LV Dysfunction

Improved Outcomes With CABG vs PCI for Diabetes With LV Dysfunction

Aim of study was to determine whether treatment with percutaneous coronary intervention or coronary artery bypass grafting leads to improved outcomes in patients with diabetes, coronary artery disease, and left ventricular dysfunction.

Smartphone Application Shows Promise for Assessing Ulnar Artery Patency

Smartphone Application Shows Promise for Assessing Ulnar Artery Patency

The smartphone heart rate monitoring application had higher diagnostic accuracy compared with standard physical examination for determining ulnar artery patency prior to radial access.

Pulmonary Hypertension Mortality Following Cardiac Catheterization

Pulmonary Hypertension Mortality Following Cardiac Catheterization

Patients with pulmonary hypertension have a high risk for adverse events during and following cardiac catheterization, but high case volume may help ameliorate this risk.

Patent Foramen Ovale Characteristics May Predict Benefits of PFO Closure

Patent Foramen Ovale Characteristics May Predict Benefits of PFO Closure

Patent foramen ovale closure resulted in a lower recurrence of stroke in patients with cryptogenic stroke and high-risk PFO characteristics.

FDA Approves Mechanical Heart Valve for Use in Infants

FDA Approves Mechanical Heart Valve for Use in Infants

The FDA has approved a new size of the Masters Series Mechanical Heart Valve with Hemodynamic Plus Sewing Cuff for use in newborn patients with heart defects.

PCI: Prevalence and Effect of Silent Diabetes

PCI: Prevalence and Effect of Silent Diabetes

Abnormal glucose metabolism may be present in patients with undetected diabetes after percutaneous coronary intervention.

LVAD Shared Decision-Making Program Demonstrates Improved Patient Knowledge

LVAD Shared Decision-Making Program Demonstrates Improved Patient Knowledge

A shared decision-making program between patients with end-stage heart failure being considered for destination therapy left ventricular assist device and their caregivers was associated with improvement in patient knowledge.

Patent Foramen Ovale Closure Does Not Reduce Migraine Headaches

Patent Foramen Ovale Closure Does Not Reduce Migraine Headaches

Percutaneous closure of patent foramen ovale is not associated with a reduction in migraine headaches in patients with and without aura.

Rheumatic Heart Disease Mortality in Valve Replacement Surgery

Rheumatic Heart Disease Mortality in Valve Replacement Surgery

Thrombocytopenia at hospital admission may be an independent predictor for in-hospital mortality in patients with rheumatic heart disease undergoing valve replacement surgery.

Multivessel CAD With Diabetes: Choosing an Optimal Revascularization Strategy

Multivessel CAD With Diabetes: Choosing an Optimal Revascularization Strategy

Patients with multivessel coronary artery disease and diabetes may benefit more from coronary artery bypass grafting surgery vs percutaneous coronary intervention.

Ruptured Abdominal Aortic Aneurysms: Open vs Endovascular Repair

Ruptured Abdominal Aortic Aneurysms: Open vs Endovascular Repair

Endovascular strategy is associated with better survival rate and decreased hospital costs compared to open repair in ruptured abdominal aortic aneurysm.

Contrast-Induced Acute Kidney Injury: Sodium Bicarbonate vs Sodium Chloride

Contrast-Induced Acute Kidney Injury: Sodium Bicarbonate vs Sodium Chloride

Intravenous sodium bicarbonate is not superior to intravenous sodium chloride for reducing acute kidney injury during angiography.

Necessity of PCI in Stable Coronary Artery Disease Questioned

Necessity of PCI in Stable Coronary Artery Disease Questioned

No evidence shows efficacy of PCI procedures for patients with stable coronary artery disease with angina.

Target Vessel Thrombosis in BVS vs Everolimus-Eluting Stents

Target Vessel Thrombosis in BVS vs Everolimus-Eluting Stents

Patients who received bioresorbable vascular scaffolds had higher rates of device thrombosis and target vessel MI compared with those who received everolimus-eluting stents.

Vessel Sizing Optimization in BVS Implantation

Vessel Sizing Optimization in BVS Implantation

Researchers analyzed 3-year outcomes in patients implanted with bioresorbable vascular scaffolds for the treatment of coronary lesions.

PCI and CABG Provide Similar Intermediate-Term Outcomes in Left Main CAD

PCI and CABG Provide Similar Intermediate-Term Outcomes in Left Main CAD

A substudy analyzed whether PCI outcomes using second generation drug eluting stents were comparable to CABG in patients with low or intermediated complexity left main coronary artery disease.

Additional Ablation for Atrial Fibrillation Not Warranted After Change in Inducibility

Additional Ablation for Atrial Fibrillation Not Warranted After Change in Inducibility

Change in inducibility status after pulmonary vein isolation is not associated with long-term freedom from recurrent arrhythmia.

Atrial Fibrillation Survival Better With Cardiac Surgery, Cox-Maze IV

Atrial Fibrillation Survival Better With Cardiac Surgery, Cox-Maze IV

Patients with atrial fibrillation had improved late survival when treated with ablation-assisted Cox-Maze IV and cardiac surgery.

Insertable Cardiac Monitor Compatible With Smartphones Approved by FDA

Insertable Cardiac Monitor Compatible With Smartphones Approved by FDA

The FDA approved the Confirm Rx insertable cardiac monitor, which is implanted under the skin in a minimally-invasive outpatient procedure.

Heart Failure Outcomes Improved With TAVR or SAVR

Heart Failure Outcomes Improved With TAVR or SAVR

Patients with heart failure who received transcatheter aortic valve replacements saw decrease in aortic valve mean gradient.

Stent Retriever vs Contact Aspiration for Ischemic Stroke Treatment

Stent Retriever vs Contact Aspiration for Ischemic Stroke Treatment

A first-line contact aspiration technique demonstrates no significant benefit over the stent retriever technique in achieving revascularization in patients with acute ischemic stroke.

Long-Term Aspirin Unnecessary Following Atrial Fibrillation Ablation

Long-Term Aspirin Unnecessary Following Atrial Fibrillation Ablation

Patients with atrial fibrillation who are at a low risk for stroke do not receive a major benefit from long-term aspirin therapy.

Is Echocardiography Missing Mild CTEPH Cases That May Benefit From Endarterectomy?

Is Echocardiography Missing Mild CTEPH Cases That May Benefit From Endarterectomy?

Pulmonary endarterectomy is an effective treatment for patients with chronic thromboembolic pulmonary hypertension.

Comparison of PCI Outcomes With Bivalirudin vs Heparin Post-STEMI or NSTEMI

Comparison of PCI Outcomes With Bivalirudin vs Heparin Post-STEMI or NSTEMI

In patients undergoing percutaneous coronary intervention for either STEMI or NSTEMI, bivalirudin and heparin produce similar outcomes.

Which Revascularization Strategy Produces Better Outcomes in Type 1 Diabetes?

Which Revascularization Strategy Produces Better Outcomes in Type 1 Diabetes?

Coronary artery bypass grafting yielded better outcomes in patients with type 1 diabetes who had multivessel disease compared with percutaneous coronary intervention.

Avalus Surgical Aortic Valve Receives FDA and European Commission Approval

Avalus Surgical Aortic Valve Receives FDA and European Commission Approval

A new pericardial aortic surgical valve has received US Food and Drug Administration and European Commission approval.

FDA Issues Safety Alert for Revascularization Device Used in Acute Ischemic Stroke

FDA Issues Safety Alert for Revascularization Device Used in Acute Ischemic Stroke

The delivery wire component of the Penumbra 3D revascularization device may break or separate during use.

FDA Approves New Pericardial Aortic Valve

FDA Approves New Pericardial Aortic Valve

The FDA approved a new pericardial aortic valve for replacement of native or prosthetic valves.

Frailty Scale Predicts Death and Disability After Aortic Valve Replacement

Frailty Scale Predicts Death and Disability After Aortic Valve Replacement

The Essential Frailty Toolset is a fast and effective predictor of death and worsening disability following valve replacement.

Anticoagulant Recall: Incorrect Dose Discovered in Bottle

Anticoagulant Recall: Incorrect Dose Discovered in Bottle

Bristol-Myers Squibb is recalling one lot of Eliquis after finding that 1 of the bottles contained the wrong dosage.

American Association for Thoracic Surgery Guidelines on Surgical Ablation for Atrial Fibrillation

American Association for Thoracic Surgery Guidelines on Surgical Ablation for Atrial Fibrillation

The American Association for Thoracic Surgery has developed evidence-based guidelines on the use of surgical ablation for atrial fibrillation.

Endovascular Treatment for Acute Ischemic Stroke Shows Benefits at 2 Years

Endovascular Treatment for Acute Ischemic Stroke Shows Benefits at 2 Years

The response to endovascular treatment for acute ischemic stroke after 2 years was as good as in the first 90 days.

Lower HbA1c Post-PCI Promotes Better Outcomes in Diabetes

Lower HbA1c Post-PCI Promotes Better Outcomes in Diabetes

Patients with HbA1c levels had lower 7-year incidence of major adverse cardiac and cerebrovascular events compared with patients with higher HbA1c levels.

Glucose Levels May Affect Functional Outcomes After Endovascular Thrombectomy

Glucose Levels May Affect Functional Outcomes After Endovascular Thrombectomy

The effect of hypoglycemia on functional outcomes after endovascular thrombectomy differs, depending on collateral status.

Instantaneous Wave-Free Ratio Noninferior to Fractional Flow Reserve for Guiding PCI

Instantaneous Wave-Free Ratio Noninferior to Fractional Flow Reserve for Guiding PCI

Both iFR and FFR groups experienced similar rates of composite nonfatal myocardial infarction, unplanned revascularization, or all-cause death within 1 year post-procedure.

ACC Updated Criteria: Coronary Revascularization in Stable Ischemic Heart Disease

ACC Updated Criteria: Coronary Revascularization in Stable Ischemic Heart Disease

Revised coronary revascularization criteria rated whether coronary interventions are appropriate in tables organized according to practice patterns.

Target Lesion Failure and Stent Thrombosis Rates Low With SYNERGY

Target Lesion Failure and Stent Thrombosis Rates Low With SYNERGY

Target lesion failure was 5.8% at 1 year after implantation with the SYNERGY stent.

Everolimus-Eluting vs Sirolimus-Eluting Stents in Coronary Artery Disease

Everolimus-Eluting vs Sirolimus-Eluting Stents in Coronary Artery Disease

After 5 years, the cumulative incidence of MACE was 6.7% in the everolimus-eluting stent group and 11.2% in the sirolimus-eluting stent group.

TAVR Demonstrates Noniferiority to Surgery in Intermediate-Risk Patients

TAVR Demonstrates Noniferiority to Surgery in Intermediate-Risk Patients

At 2 years, the estimated incidence of the primary end point was 12.6% in the TAVR group vs 14% in the surgery group.

Surgical Pulmonary Embolectomy Outcomes Not Affected by Thrombus Location

Surgical Pulmonary Embolectomy Outcomes Not Affected by Thrombus Location

Survival rates were high for patients with both central and peripheral pulmonary emboli.

Stroke Door-to-Needle Times Delayed, Affecting Outcomes

Stroke Door-to-Needle Times Delayed, Affecting Outcomes

Stroke treatment delays were attributed to inability of the care team to determine patient eligibility, hypertension needing aggressive treatment, and in-hospital delays.

Acute Ischemic Stroke: Contact Aspiration vs Stent Retriever

Acute Ischemic Stroke: Contact Aspiration vs Stent Retriever

Contact aspiration and stent retriever approaches for mechanical thrombectomy achieved similar efficacy and safety end points.

Cardiac Procedures Need Standardized Clinical Trial End Points for Neurologic Injury

Cardiac Procedures Need Standardized Clinical Trial End Points for Neurologic Injury

Standardized definitions for neurologic injury, such as stroke, hypoxic-ischemic injury, and cerebral hemorrhage were proposed by the NeuroARC initiative.

First-Generation Drug-Eluting Stent Outcomes After 10 Years

First-Generation Drug-Eluting Stent Outcomes After 10 Years

No major differences in MACE or stent thrombosis were shown between the 2 drug-eluting stents after 10 years of follow-up.

CABG Revascularization Strategies in Carotid and Coronary Artery Diseases

CABG Revascularization Strategies in Carotid and Coronary Artery Diseases

Three revascularization techniques were compared in patients with concomitant carotid and coronary artery disease undergoing CABG.

Reducing Hospital-Acquired Infections Via Enhanced Disinfection Strategies

Reducing Hospital-Acquired Infections Via Enhanced Disinfection Strategies

When ultraviolet was added to the reference disinfection method, the incidence of target organisms was reduced by 30%.

Periprocedural Anticoagulation in Atrial Fibrillation: American College of Cardiology Decision Pathway

Periprocedural Anticoagulation in Atrial Fibrillation: American College of Cardiology Decision Pathway

The American College of Cardiology released a decision pathway for managing periprocedural anticoagulation in patients with nonvalvular atrial fibrillation

Effects of Vitamin D on High-Intensity Statin Therapy for Coronary Artery Disease

Effects of Vitamin D on High-Intensity Statin Therapy for Coronary Artery Disease

Significantly decreased platelet reactivity occurred in patients who were given a new statin or an increased dose of a previous statin.

Systemic Inflammatory Response Syndrome After Congenital Heart Surgery in Children

Systemic Inflammatory Response Syndrome After Congenital Heart Surgery in Children

To reduce the incidence of systemic inflammatory response syndrome in pediatric patients after heart surgery, researchers suggest restricting blood product use.

SYNTAX Scores Linked to Long-Term Revascularization Outcomes

SYNTAX Scores Linked to Long-Term Revascularization Outcomes

Higher SYNTAX scores may predict major cardiovascular events in patients with coronary artery disease and diabetes.

LAA Closure Device in Atrial Fibrillation Yields High Success, Low Complication Rates

LAA Closure Device in Atrial Fibrillation Yields High Success, Low Complication Rates

The left atrial appendage closure device was found to have excellent success and low complication rates in a post-FDA approval study.

ACC Releases Decision Pathway for TAVR in Aortic Stenosis

ACC Releases Decision Pathway for TAVR in Aortic Stenosis

The American College of Cardiology has released guidelines for determining if patients with aortic stenosis are appropriate candidates for transcatheter aortic valve replacement.

Dual Antiplatelet Therapy vs Aspirin Alone Post-CABG in Diabetes

Dual Antiplatelet Therapy vs Aspirin Alone Post-CABG in Diabetes

No significant differences were observed between dual antiplatelet therapy and aspirin alone following coronary artery bypass grafting in patients with diabetes.

Timing of Noncardiac Surgery Following Percutaneous Coronary Intervention

Timing of Noncardiac Surgery Following Percutaneous Coronary Intervention

Although current guidelines recommend delaying noncardiac surgery for 6 to 12 months after drug-eluting stent implantation, new data suggest surgery may be performed earlier.

Does Sex Matter in Transcatheter Aortic Valve Therapy Outcomes?

Does Sex Matter in Transcatheter Aortic Valve Therapy Outcomes?

Although female patients experienced higher in-hospital vascular complications, their overall 1-year survival rates were better.

Amputation-Free Survival With Endovascular Therapy vs Bypass Surgery in Critical Limb Ischemia

Amputation-Free Survival With Endovascular Therapy vs Bypass Surgery in Critical Limb Ischemia

Endovascular therapy was considered noninferior to bypass surgery in patients with critical limb ischemia.

PCI Outcomes at Centers With and Without On-Site Cardiac Surgery

PCI Outcomes at Centers With and Without On-Site Cardiac Surgery

After multivariate adjustment, no significant in-hospital mortality difference was found between centers with and without on-site cardiac surgery.

FFR-Guided Revascularization in Coronary Artery Disease Raises Concern

FFR-Guided Revascularization in Coronary Artery Disease Raises Concern

A real-world study of fractional flow-reserve-guided revascularization in coronary artery disease identified several concerns with use of the technique.

Revisiting Necessity of Full Dose Triple Therapy With DAPT for Routine PCI

Revisiting Necessity of Full Dose Triple Therapy With DAPT for Routine PCI

All-cause death plus hospitalization possibly from bleeding were reduced in both rivaroxaban groups compared with the reference group.

Peripheral Artery Disease: Drug-Coated Balloon vs Percutaneous Transluminal Angioplasty

Peripheral Artery Disease: Drug-Coated Balloon vs Percutaneous Transluminal Angioplasty

At 1 year, primary patency was 82.3% for the drug-coated balloon group vs 70.9% for the percutaneous transluminal angioplasty group.

Watchman Device Linked to Low Complications, Successful Procedures

Watchman Device Linked to Low Complications, Successful Procedures

Procedural data from the WATCHMAN clinical trial presented at TCT demonstrated the device implantation success rate in patients with nonvalvular atrial fibrillation.

Stroke Prevention in TAVR: Transcatheter Cerebral Embolic Protection

Stroke Prevention in TAVR: Transcatheter Cerebral Embolic Protection

The Sentinel transcatheter cerebral embolic protection device was safe and captured 99% of debris in patients undergoing TAVR.

TAVR's Long-Term Durability and Quality of Life Outcomes

TAVR's Long-Term Durability and Quality of Life Outcomes

Transcatheter aortic valve replacement with SAPIEN valve demonstrates long-term durability and improves quality of life.

ABSORB Substudy: Bioresorbable Vascular Scaffold Safe for Diabetes

ABSORB Substudy: Bioresorbable Vascular Scaffold Safe for Diabetes

The 1-year target lesion failure was 8.3% for patients with diabetes which was significantly lower than the pre-specified goal of 12.7%.

Sex-Specific Differences in New-Onset Afib Post-CABG

Sex-Specific Differences in New-Onset Afib Post-CABG

Patients with new-onset atrial fibrillation after CABG experience higher rates of morbidity and poor long-term survival outcomes compared to women.

Left Main PCI: How Much Does Operator Experience Matter?

Left Main PCI: How Much Does Operator Experience Matter?

Patients undergoing left main PCI treated by high-volume operators had a significantly lower risk for short- and long-term cardiac death compared with those treated by less experienced operators.

TAVR With Intraprocedural Embolic Protection: Potential for Improved Neurological Outcomes

TAVR With Intraprocedural Embolic Protection: Potential for Improved Neurological Outcomes

The use of embolic protection during TAVR was associated with a lower total lesion volume and fewer new ischemic lesions.

Intravascular Ultrasound vs Aniography-Guided Stent Implantation Outcomes

Intravascular Ultrasound vs Aniography-Guided Stent Implantation Outcomes

Patients who underwent intravascular ultrasound guided drug-eluting stent implantation vs angiography-guided implantation had reductions in MACE.

Choosing the Ideal STEMI Treatment Strategy: Pharmacoinvasive vs PCI

Choosing the Ideal STEMI Treatment Strategy: Pharmacoinvasive vs PCI

Using primary percutaneous coronary intervention or a pharmacoinvasive strategy results in similar outcomes for patients with STEMI.

PCI of Concurrent Coronary Chronic Total Occlusion After STEMI

PCI of Concurrent Coronary Chronic Total Occlusion After STEMI

PCI in patients with chronic total occlusion of the left anterior descending coronary artery had significantly improved LVEF compared with control patients.

TAVR Demonstrates Positive Late Clinical Outcomes

TAVR Demonstrates Positive Late Clinical Outcomes

Late mortality after transcatheter aortic valve replacement was mostly due to noncardiac causes.

Preventing Radial Artery Occlusion in Cardiac Catheterization

Preventing Radial Artery Occlusion in Cardiac Catheterization

The rate of radial artery occlusion at 30 days after catheterization was significantly lower in patients who received prophylactic ipsilateral ulnar compression.

Bridge-to-Recovery Strategies in LVAD Implantation

Bridge-to-Recovery Strategies in LVAD Implantation

Cardiac recovery was independently predicted by age, nonischemic cardiomyopathy, time from cardiac diagnosis, lack of ICD, serum creatinine levels, and LV end-diastolic dimensions.

Coronary Artery Calcification Increases Ischemic Risk in Women After PCI

Coronary Artery Calcification Increases Ischemic Risk in Women After PCI

Women with moderate or severe coronary artery calcification had higher risks of death, MI, or target revascularization, despite new-generation drug-eluting stents.

Cangrelor Reduces PCI Complications in ACS, Stable Angina

Cangrelor Reduces PCI Complications in ACS, Stable Angina

Cangrelor provided similar perioprocedural benefits, as well as reduced risk of bleeding, as clopidogrel in patients with stable angina and acute coronary syndromes.

Assessing Effect of Obesity on LVAD Outcomes

Assessing Effect of Obesity on LVAD Outcomes

Obese patients were at increased risk of death compared with patients of normal weight.

Characteristics of Transcatheter Heart Valve Thrombosis After TAVR

Characteristics of Transcatheter Heart Valve Thrombosis After TAVR

Study reveals incidence, risk factors, and clinical characteristics of transcatheter aortic heart valve thrombosis after TAVR.

Atrial Fibrillation Associated With Increased Complications After PCI

Atrial Fibrillation Associated With Increased Complications After PCI

Patients with a history of atrial fibrillation were more likely to have postprocedural bleeding, blood transfusion, heart failure, cardiogenic shock, and in-hospital mortality.

FDA Approves Transcatheter Heart Valves in Intermediate-Risk Patients

FDA Approves Transcatheter Heart Valves in Intermediate-Risk Patients

Two clinical studies were conducted to assess safety and effectiveness in patients with aortic stenosis at intermediate risk.

Antiplatelet Therapy With Vitamin K Antagonists Does Not Reduce Stroke in Afib After TAVR

Antiplatelet Therapy With Vitamin K Antagonists Does Not Reduce Stroke in Afib After TAVR

No differences between monotherapy and multiple anthrombotic therapy in rates of stroke, MACE, or death.

Smoking Status Influence on Clopidogrel Response

Smoking Status Influence on Clopidogrel Response

Researchers observed a "significant inverse correlation" between P2Y12 reaction units and hemoglobin.

Beta Blockers Following PCI Did Not Reduce Mortality in Elderly Patients

Beta Blockers Following PCI Did Not Reduce Mortality in Elderly Patients

No reduction in cardiovascular morbidity or mortality at 30-day and 3-year follow-up.

Sign Up for Free e-Newsletters